Médecins Sans Frontières calls for affordable access to critical TB drug bedaquiline
Médecins Sans Frontières to Johnson & Johnson: We need affordable and sustainable supply of bedaquiline.
On 17 September 2018, Médecins Sans Frontières sent an open letter to Johnson & Johnson urging the pharmaceutical corporation to take action so that countries can access an affordable and sustainable supply of the critical drug bedaquiline, used to treat multidrug-resistant TB.
Source:
Médecins Sans Frontières
